Home › NDC Lookup › RxCUI directory › RxCUI 1598073

Ivermectin 10 MG/ML Topical Cream [Soolantra] — RxCUI 1598073

RxNorm drug concept · Semantic branded drug
RxCUI 1598073 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1598073
Official nameIvermectin 10 MG/ML Topical Cream [Soolantra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSoolantra 1 % Topical Cream; Soolantra 10 MG/ML Topical Cream
FDA products mapped1
Package NDCs mapped5
Reported Medicaid activity (SDUD)219 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ivermectin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Tablets treat intestinal strongyloidiasis and onchocerciasis. Lotions treat head lice, and the cream treats the bumps and pimples of rosacea.
  • Stromectol and ivermectin tablets are usually a single dose based on your weight. Take it on an empty stomach with water. Your doctor may order follow-up stool tests to confirm the...
  • Apply it to dry hair and scalp, covering everything from the scalp outward. Leave it on for 10 minutes, then rinse with water only. Wait 24 hours before shampooing, and don't reuse...
  • Dizziness, itching, rash, nausea, diarrhea, and tiredness were reported. If you're treated for onchocerciasis, fever, swollen glands, and joint pain can happen as the parasites die...
📖 Read our full Ivermectin guide →

🕸️ Concept Web — How Ivermectin 10 MG/ML Topical Cream [Soolantra] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ivermectin 10 MG/ML Topical Cream [Soolantra] RxCUI 1598073

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ivermectin 6069
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Soolantra 1598069
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ivermectin Topical Cream 1598067
    • Ivermectin Topical Product 1160348
    • Ivermectin Topical Cream [Soolantra] 1598071
    • Soolantra Topical Product 1598072
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ivermectin 10 MG/ML Topical Cream SCD · 1598068
  • Ivermectin 10 MG/ML SCDC · 855486
  • Ivermectin Topical Cream SCDF · 1598067
  • Ivermectin Topical Product SCDG · 1160348

Brand-Name Concepts

  • Ivermectin 10 MG/ML [Soolantra] SBDC · 1598070
  • Ivermectin Topical Cream [Soolantra] SBDF · 1598071
  • Soolantra Topical Product SBDG · 1598072
  • Soolantra BN · 1598069

📦 FDA Products & Package NDCs

1 product · 5 package NDCs
5 package NDCs map to RxCUI 1598073 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00299-3823-00 2 g in 1 TUBE (0299-3823-00) SOOLANTRA Galderma Laboratories, L.P. 2019-11-01
00299-3823-02 1 TUBE in 1 BLISTER PACK (0299-3823-02) / 2 g in 1 TUBE SOOLANTRA Galderma Laboratories, L.P. 2015-01-01
00299-3823-30 1 TUBE in 1 CARTON (0299-3823-30) / 30 g in 1 TUBE SOOLANTRA Galderma Laboratories, L.P. 2015-01-01
00299-3823-45 1 TUBE in 1 CARTON (0299-3823-45) / 45 g in 1 TUBE SOOLANTRA Galderma Laboratories, L.P. 2015-01-01
00299-3823-60 1 TUBE in 1 CARTON (0299-3823-60) / 60 g in 1 TUBE SOOLANTRA Galderma Laboratories, L.P. 2015-01-01
Observed labelers: Galderma Laboratories, L.P. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$15.5173
Range $15.5173–$15.5173 · middle 50% $15.5173–$15.5173 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.